首頁 > 市場調查報告書 > 製藥

生物製劑基因治療學和RNAi 分子標靶治療學核酸藥物

市場調查報告書

商品編碼

1747082

日本適體市場報告（依類型（核酸、胜肽）、應用（診斷、治療、研發等）及地區）2025-2033

Japan Aptamers Market Report by Type (Nucleic Acid, Peptide), Application (Diagnostics, Therapeutics, Research and Developments, and Others), and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 119 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年，日本適體市場規模達1.83億美元。展望未來， IMARC Group預計到2033年，市場規模將達到6.34億美元，2025-2033年期間的複合年成長率（CAGR）為14.80%。對創新診斷和治療解決方案的需求不斷成長、生物標記檢測應用的不斷提升以及與尖端藥物輸送系統的日益融合，是推動市場發展的關鍵因素。

適體，又稱化學抗體，是一類短小的單股脫氧核糖核酸 (DNA) 或核糖核酸 (RNA) 分子，能夠選擇性地結合特定目標分子，例如蛋白質、小分子和整個細胞。它們透過指數級富集系統進化配體而人工合成。它們在各種條件下都保持穩定，包括極端溫度和pH值，因此在各種環境中都具有實用性。它們可以化學合成，純度高，從而實現經濟高效的生產和客製化。它們通常具有較低的免疫原性，這降低了在生物應用中出現免疫反應的可能性。它們能夠精確地靶向特定分子，使研究人員能夠以最佳精度研究和操控生物過程。它們廣泛用於檢測與疾病相關的生物標記的診斷檢測，這對於早期疾病檢測至關重要。此外，它們在環境監測中也廣泛用於檢測污染物。

日本適體市場趨勢：

日本對創新診斷和治療解決方案的需求不斷成長，這是有利於市場成長的關鍵因素之一。此外，適體在檢測與癌症和傳染病等疾病相關的生物標記中的應用日益廣泛，這也促進了市場的成長。此外，日本強勁的製藥和生物技術產業也促進了市場的成長。此外，適體與尖端藥物輸送系統的整合也支持了市場的成長。此外，學術機構、生技公司和製藥巨頭之間日益增多的合作正在推動研發活動，以充分利用適體的治療潛力，從而進一步促進市場成長。此外，創新生物技術產品的監管支援和簡化的核准流程也為市場前景提供了良好的支撐。此外，日本監管機構正在積極推動生物製藥（包括基於適體的藥物）的開發和商業化。此外，正在進行的新型適體修飾和輸送機制研究也對市場產生了積極影響。研究人員不斷改進適體的穩定性、特異性和藥物動力學，使其作為治療和診斷工具更有效。此外，日本基於適體的即時診斷設備（POC）的開發正在興起。這些使用者友善、快速的檢測平台利用適體的特異性在臨床環境中檢測生物標記或病原體。此外，日本老齡人口的不斷成長，使人們極易患上多種慢性疾病，這也促進了市場的成長。日本領先的大學和研究機構積極參與適體相關研究，培養了創新和知識交流的文化。這種學術實力有助於新型適體的開發。

日本適體市場細分：

類型洞察：

核酸
胜肽

應用程式洞察：

診斷
療法
研究與開發
其他

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外，報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本適體市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本適體市場有何影響？
日本適體市場按類型分類是怎樣的？
日本適體市場根據應用如何分類？
日本適體市場的價值鏈分為哪些階段？
日本適體的主要促進因素和挑戰是什麼？
日本適體市場的結構是怎麼樣的？主要參與者是誰？
日本適體市場的競爭程度如何？

本報告回答的關鍵問題：

日本適體市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本適體市場有何影響？
日本適體市場按類型分類是怎樣的？
日本適體市場根據應用如何分類？
日本適體市場的價值鏈分為哪些階段？
日本適體的主要促進因素和挑戰是什麼？
日本適體市場的結構是怎麼樣的？主要參與者是誰？
日本適體市場的競爭程度如何？

Japan aptamers market size reached USD 183.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 634.0 Million by 2033, exhibiting a growth rate (CAGR) of 14.80% during 2025-2033. The rising demand for innovative diagnostic and therapeutic solutions, increasing utilization in detecting biomarkers, and the growing integration into cutting-edge drug delivery systems represent some of the key factors driving the market.

Aptamers, also known as chemical antibodies, are short, single-stranded deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) molecules that can selectively bind to specific target molecules, such as proteins, small molecules, and whole cells. They are artificially synthesized through the systematic evolution of ligands by exponential enrichment process. They are stable under a wide range of conditions, including extreme temperatures and pH levels, and contribute to their utility in diverse environments. They can be chemically synthesized with high purity, allowing for cost-effective production and customization. They generally have low immunogenicity, which reduces the likelihood of immune responses when used in biological applications. They provide precise targeting of specific molecules, enabling researchers to study and manipulate biological processes with optimal accuracy. They are widely used in diagnostic assays for detecting biomarkers associated with diseases, making them invaluable for early disease detection. Besides this, they find numerous applications in environmental monitoring to detect pollutants and contaminants.

Japan Aptamers Market Trends:

The escalating demand for innovative diagnostic and therapeutic solutions in Japan represents one of the key factors favoring the market growth. Additionally, the increasing utilization of aptamers in detecting biomarkers associated with diseases like cancer and infectious diseases is strengthening the growth of the market. Along with this, the presence of a robust pharmaceutical and biotechnology sector in Japan is contributing to the market growth. Apart from this, the integration of aptamers into cutting-edge drug delivery systems is supporting the market growth. Moreover, rising collaborations between academic institutions, biotech firms, and pharmaceutical giants are driving research and development (R&D) activities to harness the therapeutic potential of aptamers, further bolstering the market growth. Besides this, the regulatory support and streamlined approval processes for innovative biotechnological products is offering a favorable market outlook. Furthermore, the regulatory authorities in the country are actively working to facilitate the development and commercialization of biopharmaceuticals, including aptamer-based drugs. Besides this, the ongoing research into novel aptamer modifications and delivery mechanisms is positively influencing the market. Researchers are continually improving the stability, specificity, and pharmacokinetics of aptamers, making them even more effective as therapeutic and diagnostic tools. Additionally, Japan is witnessing a rise in the development of aptamer-based point-of-care (POC) diagnostic devices. These user-friendly, rapid-testing platforms leverage the specificity of aptamers to detect biomarkers or pathogens in clinical settings. Moreover, the expanding aging population in the country, which is highly susceptible to several chronic diseases, is facilitating the market growth. Leading universities and research institutions in Japan are actively engaged in aptamer-related studies, fostering a culture of innovation and knowledge exchange. This academic prowess contributes to the development of novel aptamers.

Japan Aptamers Market Segmentation:

Type Insights:

Nucleic Acid
Peptide

Application Insights:

Diagnostics
Therapeutics
Research and Developments
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan aptamers market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan aptamers market?
What is the breakup of the Japan aptamers market on the basis of type?
What is the breakup of the Japan aptamers market on the basis of application?
What are the various stages in the value chain of the Japan aptamers market?
What are the key driving factors and challenges in the Japan aptamers?
What is the structure of the Japan aptamers market and who are the key players?
What is the degree of competition in the Japan aptamers market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Aptamers Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Aptamers Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Aptamers Market - Breakup by Type

6.1 Nucleic Acid
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Peptide
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)

7 Japan Aptamers Market - Breakup by Application

7.1 Diagnostics
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Therapeutics
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Research and Developments
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Others
- 7.4.1 Historical and Current Market Trends (2019-2024)
- 7.4.2 Market Forecast (2025-2033)

8 Japan Aptamers Market - Competitive Landscape

8.1 Overview
8.2 Market Structure
8.3 Market Player Positioning
8.4 Top Winning Strategies
8.5 Competitive Dashboard
8.6 Company Evaluation Quadrant

9 Profiles of Key Players

9.1 Company A
- 9.1.1 Business Overview
- 9.1.2 Product Portfolio
- 9.1.3 Business Strategies
- 9.1.4 SWOT Analysis
- 9.1.5 Major News and Events
9.2 Company B
- 9.2.1 Business Overview
- 9.2.2 Product Portfolio
- 9.2.3 Business Strategies
- 9.2.4 SWOT Analysis
- 9.2.5 Major News and Events
9.3 Company C
- 9.3.1 Business Overview
- 9.3.2 Product Portfolio
- 9.3.3 Business Strategies
- 9.3.4 SWOT Analysis
- 9.3.5 Major News and Events
9.4 Company D
- 9.4.1 Business Overview
- 9.4.2 Product Portfolio
- 9.4.3 Business Strategies
- 9.4.4 SWOT Analysis
- 9.4.5 Major News and Events
9.5 Company E
- 9.5.1 Business Overview
- 9.5.2 Product Portfolio
- 9.5.3 Business Strategies
- 9.5.4 SWOT Analysis
- 9.5.5 Major News and Events

10 Japan Aptamers Market - Industry Analysis

10.1 Drivers, Restraints, and Opportunities
- 10.1.1 Overview
- 10.1.2 Drivers
- 10.1.3 Restraints
- 10.1.4 Opportunities
10.2 Porters Five Forces Analysis
- 10.2.1 Overview
- 10.2.2 Bargaining Power of Buyers
- 10.2.3 Bargaining Power of Suppliers
- 10.2.4 Degree of Competition
- 10.2.5 Threat of New Entrants
- 10.2.6 Threat of Substitutes
10.3 Value Chain Analysis